- 现金
- 356 元
- 精华
- 0
- 帖子
- 158
- 注册时间
- 2012-8-18
- 最后登录
- 2012-10-18
|
本帖最后由 肝胆速递 于 2012-8-24 23:47 编辑
Genotype impact on long-term virological outcome of chronic hepatitis B virus infection
基因型对慢性乙肝的影响
肝胆速递:HBV基因型A,B和D型的DNA载量可随时间逐渐下降,但高复制的C或者D型常常持续高复制
Genotype impact on long-term virological outcome of chronic hepatitis B virus infection
Sebastian Malmström ,
Anders Eilard ,
Simon B. Larsson ,
Charles Hannoun ,
Gunnar Norkrans ,
Magnus Lindhemail address
Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Received 14 December 2011; received in revised form 22 February 2012; accepted 17 April 2012. published online 21 May 2012.
Abstract
Background
The importance of hepatitis B virus (HBV) genotype on the clinical course of chronic HBV infection is not yet clarified.
Objectives
To investigate genotype impact on long-term virological outcome of chronic HBV infection.
Study design
HBsAg, HBeAg, ALT and HBV DNA levels were determined after a median of 9.2years of follow-up of 124 adults with chronic HBV infection, of whom 33 were HBeAg-positive at inclusion.
Results
HBV DNA levels decreased significantly in patients carrying genotype A (n=28), B (n=21) or D (n=63), but not in those with genotype C infection (n=12). Loss of HBeAg was seen in 44% (4/9) of patients with genotype C, as compared with 92% (22/24) with non-C genotypes. Loss of HBsAg was seen in 36% (10/28) patients with genotype A, 5% (1/21) with B, 0% (0/12) with C, and 11% (7/63) with genotype D.
Conclusions
HBV DNA levels decreased over time in patients infected with genotypes A, B or D. However, highly active genotype C or D infection often remained highly active, implying a risk for progressive liver damage.
B型肝炎病毒(HBV)基因型对慢性HBV感染的临床过程的重要性尚未明确。
目标
调查基因型的影响,长期的慢性HBV感染者的病毒学结果。
研究设计
乙型肝炎表面抗原(HBsAg),e抗原,ALT和HBV DNA水平确定后,中位数为9.2年后续的124名成人慢性HBV感染者,其中33例HBeAg阳性的,包容的。
结果
HBV DNA水平下降明显的患者进行基因型A(N =28),B(N= 21)或D组(n =63),而不是在那些与C基因型感染者(n =12)。 HBeAg消失,92%(22/24),与非C基因型相比,C基因型的患者中有44%(4/9)。 HBsAg消失36%(10/28)患者的基因型A,5%(1/21),其中B,C,0%(0/12)和11%(7/63),基因型D。
结论
随着时间的推移感染基因型A,B或D。然而,高活性基因型C或D感染的患者HBV DNA水平下降,经常保持高度活跃,暗示性肝损伤的风险。
|
|